rs5763

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001061.7(TBXAS1):​c.1349C>A​(p.Thr450Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0188 in 1,613,866 control chromosomes in the GnomAD database, including 337 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 22 hom., cov: 33)
Exomes 𝑓: 0.019 ( 315 hom. )

Consequence

TBXAS1
NM_001061.7 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0840

Publications

25 publications found
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TBXAS1 Gene-Disease associations (from GenCC):
  • ghosal hematodiaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013301253).
BP6
Variant 7-140015845-C-A is Benign according to our data. Variant chr7-140015845-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 287493.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0141 (2147/152300) while in subpopulation NFE AF = 0.023 (1563/68026). AF 95% confidence interval is 0.022. There are 22 homozygotes in GnomAd4. There are 991 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBXAS1NM_001061.7 linkc.1349C>A p.Thr450Asn missense_variant Exon 11 of 13 ENST00000448866.7 NP_001052.3 P24557-1Q53F23

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBXAS1ENST00000448866.7 linkc.1349C>A p.Thr450Asn missense_variant Exon 11 of 13 1 NM_001061.7 ENSP00000402536.3 P24557-1

Frequencies

GnomAD3 genomes
AF:
0.0141
AC:
2146
AN:
152182
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00372
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0134
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00517
Gnomad FIN
AF:
0.00810
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0230
Gnomad OTH
AF:
0.0211
GnomAD2 exomes
AF:
0.0141
AC:
3529
AN:
250862
AF XY:
0.0145
show subpopulations
Gnomad AFR exome
AF:
0.00246
Gnomad AMR exome
AF:
0.00691
Gnomad ASJ exome
AF:
0.0180
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0102
Gnomad NFE exome
AF:
0.0224
Gnomad OTH exome
AF:
0.0163
GnomAD4 exome
AF:
0.0193
AC:
28250
AN:
1461566
Hom.:
315
Cov.:
32
AF XY:
0.0191
AC XY:
13903
AN XY:
727120
show subpopulations
African (AFR)
AF:
0.00290
AC:
97
AN:
33478
American (AMR)
AF:
0.00733
AC:
328
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0181
AC:
472
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00671
AC:
579
AN:
86258
European-Finnish (FIN)
AF:
0.0117
AC:
619
AN:
53106
Middle Eastern (MID)
AF:
0.0165
AC:
95
AN:
5768
European-Non Finnish (NFE)
AF:
0.0225
AC:
25049
AN:
1112006
Other (OTH)
AF:
0.0167
AC:
1010
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1676
3352
5028
6704
8380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
894
1788
2682
3576
4470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0141
AC:
2147
AN:
152300
Hom.:
22
Cov.:
33
AF XY:
0.0133
AC XY:
991
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00371
AC:
154
AN:
41546
American (AMR)
AF:
0.0133
AC:
204
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
65
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4828
European-Finnish (FIN)
AF:
0.00810
AC:
86
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0230
AC:
1563
AN:
68026
Other (OTH)
AF:
0.0208
AC:
44
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
115
231
346
462
577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0199
Hom.:
194
Bravo
AF:
0.0139
TwinsUK
AF:
0.0221
AC:
82
ALSPAC
AF:
0.0218
AC:
84
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.0207
AC:
178
ExAC
AF:
0.0147
AC:
1783
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.0214
EpiControl
AF:
0.0217

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 03, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
9.6
DANN
Benign
0.55
DEOGEN2
Benign
0.012
.;T;.;.;T;.
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.81
T;T;.;T;.;T
MetaRNN
Benign
0.013
T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
PhyloP100
0.084
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.23
N;N;.;.;.;.
REVEL
Benign
0.075
Sift
Benign
0.082
T;D;.;.;.;.
Sift4G
Benign
0.091
T;T;.;.;.;.
Polyphen
0.0040
.;.;B;B;.;.
Vest4
0.14
MPC
0.14
ClinPred
0.0022
T
GERP RS
0.30
gMVP
0.55
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5763; hg19: chr7-139715645; API